Skip to main content
SpringerLink
Log in

Switch to anidulafungin improves liver function

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. common terminology criteria for adverse events

Reference

  • Jung DS, et al. Switching to anidulafungin from caspofungin in cancer patients in the setting of liver dysfunction is associated with improvement of liver function tests. Journal of Antimicrobial Chemotherapy : 25 Aug 2015. Available from: URL: http://doi.org/10.1093/jac/dkv235

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Switch to anidulafungin improves liver function. Reactions Weekly 1572, 11 (2015). https://doi.org/10.1007/s40278-015-1036-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-015-1036-5

Search

Navigation